|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation显示文摘 | Elizabeth Montgomery Mary P Bronner John R Goldblum Joel K Greenson Marian M Haber John Hart Laura W Lamps Gregory Y Lauwers Audrey J Lazenby David N Lewin Marie E Robert Alicia Y Toledano Yu Shyr Kay Washington | 2001 | Human Pathology2001，，4： | 3 |
| 2 | Bovine immunoglobulin protein isolates for the nutritional management of enteropathy显示文摘The gastrointestinal tract is responsible for a multitude of digestive and immune functions which depend upon the balanced interaction of the intestinal microbiota, diet, gut barrier function, and mucosal immune response. Disruptions in one or more of these factors can lead to intestinal disorders or enteropathies which are characterized by intestinal inflammation, increased gut permeability, and reduced capacity to absorb nutrients. Enteropathy is frequently associated with human immunodeficiency virus(HIV) infection, inflammatory bowel disease, autoimmune enteropathy, radiation enteritis, and irritable bowel syndrome(IBS), where pathologic changes in the intestinal tract lead to abdominal discomfort, bloating, abnormal bowel function(e.g., diarrhea, urgency, constipation and malabsorption). Unfortunately, effective therapies for the management ofenteropathy and restoring intestinal health are still not available. An accumulating body of preclinical studies has demonstrated that oral administration of plasmaor serum-derived protein concentrates containing high levels of immunoglobulins can improve weight, normalize gut barrier function, and reduce the severity of enteropathy in animal models. Recent studies in humans, using serum-derived bovine immunoglobulin/protein isolate, demonstrate that such protein preparations are safe and improve symptoms, nutritional status, and various biomarkers associated with enteropathy. Benefits have been shown in patients with HIV infection or diarrhea-predominant IBS. This review summarizes preclinical and clinical studies with plasma/serum protein concentrates and describes the effects on host nutrition, intestinal function, and markers of intestinal inflammation. It supports the concept that immunoglobulin-containing protein preparations may offer a new strategy for restoring functional homeostasis in the intestinal tract of patients with enteropathy. | Bryon W Petschow Anthony T Blikslager Eric M Weaver Joy M Campbell Javier Polo Audrey L Shaw Bruce P Burnett Gerald L Klein J Marc Rhoads | 2014 | World Journal of Gastroenterology2014，20，33： | 2 |
| 3 | Synthesis of 5-substituted-1H-indol- 2-yl-1H-quinolin-2-ones: a novel class of KDR kinase inhibitors显示文摘 | JEFFREY T K AUDREY W QU Chuan-xing | 2005 | J Org Chem2005，70，7： | 1 |
| 4 | Distribution of heavy metals in near-shore sediments of the swan river estuary,western Australia显示文摘 | ANDERSON W R ALISTAIR E R AUDREY T B | 2000 | Water Air and Soil Pollution2000，124，： | 1 |
| 5 | Sustainable systems theory:ecological and other aspects显示文摘 | CHRISTOPHER W PAWLOWSKI AUDREY L MAYER N THERESA HOAGLAND | 2005 | Journal of Cleaner Production2005，，13： | 1 |
| 6 | Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: A follow-up study based on 138 cases from a diagnostic variability study显示文摘 | Elizabeth Montgomery John R Goldblum Joel K Greenson Marian M Haber Laura W Lamps Gregory Y Lauwers Audrey J Lazenby David N Lewin Marie E Robert Kay Washington Marianna L Zahurak John Hart | 2001 | Human Pathology2001，，： | 1 |
| 7 | Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation显示文摘 | Elizabeth Montgomery Mary P Bronner John R Goldblum Joel K Greenson Marian M Haber John Hart Laura W Lamps Gregory Y Lauwers Audrey J Lazenby David N Lewin Marie E Robert Alicia Y Toledano Yu Shyr Kay Washington | 2001 | Human Pathology2001，，： | 1 |
| 8 | Ocular damage secondary to lights and lasers: How to avoid and treat if necessary显示文摘An armamentarium of the latest light and laser technologies are used by physicians of different disciplines to address a variety of aesthetic challenges in the periocular region and throughout the body. If improperly used, these modalities can inflict serious ocular injury on the patient, support personnel, and operator. It is paramount that providers involved in operating these technologies be knowledgeable about the physical and clinically relevant properties of the unit being used. This involves training in the proper utilization, appropriate treatment parameters, and safety measure for each. Selection of the appropriate eye protection is particularly important for both the patient and the personnel. It is also imperative for the laser operator to understand the range of potential ocular complications associated with the cosmetic use of lasers and lights, to recognize the signs and symptoms associated with ocular damage, and to provide efficient first aid measures should damage ensue. Possible ocular complications related to the cosmetic use of lasers and lights range from mild eyelid swelling and erythema to potentially blinding macular injury. Ocular injury may also be inflicted by the improper selection or placement of eye protection.A complete ophthalmologic evaluation and timely management of potential complications is mandated when there is any concern for ocular injury. | Mohamed S Sayed Marcus J Ko Audrey C Ko Wendy W Lee | 2014 | World Journal of Ophthalmology2014，4，1： | 1 |
| 9 | Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation显示文摘 | Elizabeth Montgomery Mary P Bronner John R Goldblum Joel K Greenson Marian M Haber John Hart Laura W Lamps Gregory Y Lauwers Audrey J Lazenby David N Lewin Marie E Robert Alicia Y Toledano Yu Shyr Kay Washington | 2001 | Human Pathology2001，，4： | 1 |
| 10 | 查看详情显示文摘 | Audrey L M Christopher W P Heriberto C | | 0，，： | 1 |
| 11 | Community-associated methicillin-resistant staphylococcus aureus in pediatric patients 显示文摘 | Theresa JO John M Audrey W | 2005 | Emerg Infect Dis2005，11，6： | 1 |
| 12 | Global prevalence of hepatitis B virus serological markers among healthcare workers:A systematic review and meta-analysis显示文摘BACKGROUND The hepatitis B virus(HBV)infection is a global public health concern that affects about 2 billion people and causes 1 million people deaths yearly.HBV is a bloodborne disease and healthcare workers(HCWs)are a high-risk group because of occupational hazard to patients’blood.Different regions of the world show a highly variable proportion of HCWs infected and/or immunized against HBV.Global data on serologic markers of HBV infection and immunization in HCWs are very important to improve strategies for HBV control.AIM To determine the worldwide prevalence of HBV serological markers among HCWs.METHODS In this systematic review and meta–analyses,we searched PubMed and Excerpta Medica Database(Embase)to identify studies published between 1970 and 2019 on the prevalence of HBV serological markers in HCWs worldwide.We also manually searched for references of relevant articles.Four independent investigators selected studies and included those on the prevalence of each of the HBV serological markers including hepatitis B surface antigen(HBsAg),hepatitis e antigen(HBeAg),immunoglobulin M anti-HBc,and anti-HBs.Methodological quality of eligible studies was assessed and random-effect model meta-analysis resulted in the pooled prevalence of HBV serological markers HBV infection in HCWs.Heterogeneity(I²)was assessed using theχ²test on Cochran’s Q statistic and H parameters.Heterogeneity’sources were explored through subgroup and metaregression analyses.This study is registered with PROSPERO,number CRD42019137144.RESULTS We reviewed 14059 references,out of which 227 studies corresponding to 448 prevalence data among HCWs(224936 HCWs recruited from 1964 to 2019 in 71 countries)were included in this meta-analysis.The pooled seroprevalences of current HBsAg,current HBeAg,and acute HBV infection among HCWs were 2.3%[95% confidence interval(CI):1.9-2.7],0.2%(95%CI:0.0-1.7),and 5.3%(95%CI:1.4-11.2),respectively.The pooled seroprevalences of total immunity against HBV and immunity acquired by natural HBV infection in HCWs were 56.6%(95%CI:48.7-63.4)and 9.2%(95%CI:6.8-11.8),respectively.HBV infection was more prevalent in HCWs in low-income countries,particularly in Africa.The highest immunization rates against HBV in HCWs were recorded in urban areas and in high-income countries including Europe,the Eastern Mediterranean and the Western Pacific.CONCLUSION New strategies are needed to improve awareness,training,screening,vaccination,post-exposure management and treatment of HBV infection in HCWs,and particularly in low-income regions. | Gadji Mahamat Sebastien Kenmoe Etheline W Akazong Jean Thierry Ebogo-Belobo Donatien Serge Mbaga Arnol Bowo-Ngandji Joseph Rodrigue Foe-Essomba Marie Amougou-Atsama Chavely Gwladys Monamele Chris Andre Mbongue Mikangue Ginette Irma Kame-Ngasse Jeannette Nina Magoudjou-Pekam Cromwel Zemnou-Tepap Dowbiss Meta-Djomsi Martin Maidadi-Foudi Sabine Aimee Touangnou-Chamda Audrey Gaelle Daha-Tchoffo Abdel Aziz Selly-Ngaloumo Rachel Audrey Nayang-Mundo Jacqueline Felicite Yengue Jean Bosco Taya-Fokou Lorraine K M Fokou Raoul Kenfack-Momo Dimitri Tchami Ngongang Efietngab Atembeh Noura Herve Raoul Tazokong Cynthia Paola Demeni Emoh Cyprien Kengne-Nde Jean Joel Bigna Onana Boyomo Richard Njouom | 2021 | World Journal of Hepatology2021，13，9： | 1 |
| 13 | Kawasaki syndrome 显示文摘 | Dorothy W Wortmann M D Audrey W | 1990 | Rheum Dis Clin Nor Am1990，16，2： | 1 |
| 14 | Sustainability:ecological,social,economic,technological,and systems perspectives显示文摘 | Heriberto Cabezas Christopher W Pawlowski Audrey L Mayer | 2003 | Clean Technologies and Environmental Policy2003，5，3： | 1 |
| 15 | Characterization of receptors for endothelins in the perfused arterial and venous mesenteric vasculatures of the rat显示文摘 | Audrey C Timothy D W | 1993 | Br J Pharmacol1993，110，： | 1 |
| 16 | An Interview with Toni Morrison显示文摘 | Jones Bessie W Audrey Vision | | 0，，： | 1 |
| 17 | Conceptual model development for invasive species and a regional risk assessment case study:The european green crab,carcinus maenas,at cherry point,washington,USA显示文摘 | Colnar Audrey Landis W G | 2007 | Human and Ecological Risk Assessment2007，13，36： | 1 |
| 18 | Disruption of the gene XRN1,coding for a 5′→ 3′ exoribonuclease,restricts yeast cell growth显示文摘 | Frank W L Audrey S | 1990 | Genetics1990，95，1： | 1 |
| 19 | Community-associated methicillin-resistant staphylococcus aureus in pediatric patients显示文摘 | Theresa J O John M Audrey W | 2005 | Emerg Infect Dis2005，11，： | 1 |
| 20 | Confirmatory assay for the determination of tetracycline, oxytrtracycline, chlortrtracycline and its isomers in myscle and kidney using liquid chromatography-mass spectrometry显示文摘 | John Blanchflower W Robert J McCracken Audrey S Haggan | 1997 | Journal of Chromatography B1997，692，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员